SCHEMBL4963711

SCHEMBL4963711

COc1cc(-c2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2N)c(F)c(F)c1C=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 17/20 0.61
▸ CCND1 P24385 14/20 0.61
▸ CDK1 P06493 13/20 0.61
▸ CDK4 P11802 12/20 0.61
▸ CDK6 Q00534 4/20 0.59
▸ CDK5 Q00535 2/20 0.59
▸ CDK9 P50750 2/20 0.59
▸ CASK O14936 1/20 0.59
▸ ROCK2 O75116 1/20 0.59
▸ CDKL5 O76039 1/20 0.59
▸ STK10 O94804 1/20 0.59
▸ CDK14 O94921 1/20 0.59
▸ ABL1 P00519 1/20 0.59
▸ EGFR P00533 1/20 0.59
▸ MAK P20794 1/20 0.59
▸ CDK11B P21127 1/20 0.59
▸ TTK P33981 1/20 0.59
▸ CLK1 P49759 1/20 0.59
▸ CLK2 P49760 1/20 0.59
▸ CLK3 P49761 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772989 0.90 CDK2 (0.64) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4356420 0.76 CDK1 (1.00) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4360093 0.76 CDK1 (1.00) CDK2CCND1CDK1CDK4CDK6
SCHEMBL3521639 0.76 CDK2 (0.58) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4347506 0.75 CDK1 (0.92) CDK2CCND1CDK1CDK4CDK6
SCHEMBL3517632 0.75 CDK1 (1.00) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4354204 0.75 CDK1 (1.00) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4347367 0.75 CDK1 (0.85) CDK2CCND1CDK1CDK4CDK6
SCHEMBL4352866 0.75 CDK1 (0.85) CDK2CCND1CDK1CDK4CDK6
SCHEMBL3521636 0.74 CDK2 (0.58) CDK2CCND1CDK1CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1726953-B1 Biomarker for response monitoring of CDK inhibitors in the clinic HOFFMANN LA ROCHE (CH) 2008-08-20 — — EP claimed
EP-1726953-A1 Biomarker for response monitoring of CDK inhibitors in the clinic F. HOFFMANN-LA ROCHE AG (CH) 2006-11-29 — — EP claimed
EP-1726953-B1 Biomarker for response monitoring of CDK inhibitors in the clinic HOFFMANN LA ROCHE (CH) 2008-08-20 — — EP disclosed
EP-1726953-A1 Biomarker for response monitoring of CDK inhibitors in the clinic F. HOFFMANN-LA ROCHE AG (CH) 2006-11-29 — — EP disclosed
Send feedback